---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-050982"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-11-10T21:30:35+00:00"
generated_at: "2026-11-10T21:32:24.478169+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Q1 FY27 revenue $1.39M, up 25% YoY, record; gross margin 54.5%; FDA 510(k) filed Sept 9

## Summary
- Total revenue $1,391,835, up 25% year-over-year and 21% sequentially; third straight quarter above $1M and a company record, topping $1,145,802 in Q4 fiscal 2026.
- Cartridge sales $845,583 (+32% YoY, +35% sequentially), 61% of revenue; other sales $281,253 (+52% YoY), 20% of revenue.
- Gross profit $758,004, up 46% YoY; gross margin 54.5% vs 46.6% a year ago, roughly 790 bps better on manufacturing efficiencies and cartridge mix.
- Cash and equivalents $5.93M at Sept 30, 2026 vs $3.99M at June 30; 516 active customer accounts (27 added in the quarter) and 1,978 readers installed.
- FDA 510(k) submitted Sept 9, 2026 for the Intelligent Fingerprinting Drug Screening System (codeine); study showed accuracy >98%, sensitivity >94%, specificity 100% at three US sites.

## SEC filing metadata
- accession: 0001493152-26-050982
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-11-10T21:30:35+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226050982/0001493152-26-050982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226050982/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-050982
- JSON: https://secwatch.observer/filing/0001493152-26-050982.json
- Plain text: https://secwatch.observer/filing/0001493152-26-050982.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.